echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Driven by therapeutic drugs, tumors have changed from fuel vehicles to electric vehicles

    Driven by therapeutic drugs, tumors have changed from fuel vehicles to electric vehicles

    • Last Update: 2022-10-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    For more than a decade, drugs that inhibit androgen receptors such as enzalutamide have been widely used in the treatment


    A new study from the University of Michigan's Rogel Cancer Center suggests that androgen receptor inhibitors can fundamentally reshape the function of prostate tumors, in some cases even making them more aggressive


    Androgen receptors act as engines of prostate cancer cells, while androgens act as fuel, turning on androgen receptors


    Dr Joshi Alumkal, Professor of Internal Medicine at Rogel Cancer Center, said: "At the moment we need to understand how tumors become resistant to androgen receptor-targeting drugs so that we can determine how to better treat patients whose


    Alumkal wanted to know what happened when these tumors first appeared, and what happened


    The research team recruited prostate cancer patients for longitudinal studies to take biopsy samples


    To understand drug resistance, researchers often take samples


    Alumkal's continuous sampling method provides a clearer picture of how resistance to enzalumide develops


    When they compared baseline samples to progression samples from the same patient, most tumors did not show significant changes in


    That's not the only surprise


    "We know that sometimes tumors become no longer dependent on fuel and no longer dependent on androgen receptors


    But Alumkal found that in 15 percent of cases, tumors adopt another strategy


    Alumkal used the car as a metaphor for this change


    He found three cases of tumors that turned into double-negative prostate cancer — similar to electric cars


    Although the initial tumors looked similar under the microscope, the researchers found that specific genes were expressed


    Alumkal noted that the results of the continuous sampling method showed that enzalumide was improving tumor adaptation, and in some cases, the effect was remarkable


    Source text search

    Westbrook, T.
    C.
    , Guan, X.
    , Rodansky, E.
    et al.
    Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticity.
    Nat Commun 13, 5345 (2022).
    https://doi.
    org/10.
    1038/s41467-022-32701-6

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.